Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019

Author's Avatar
Nov 07, 2019
Article's Main Image

Data Include New Results from Subgroup Analysis of Cohort 1 Further Demonstrating Benefits of INOpulse